Optometrists in Panama City Beach, FL Accepting Medicare

9 Optometrists found. Showing 1 - 9

Dr Mona Patel Od Llc Optometrist Medicare: Medicare Enrolled Practice Location: 651 Grand Panama Blvd # B1-105, Panama City Beach, FL 32407 Phone: 312-890-3065

Family First Vision Care Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11570 Panama City Beach Pkwy Ste 100, Panama City Beach, FL 32407 Phone: 850-230-4433

Emerald Coast Optometry Associates, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 11570 Panama City Beach Pkwy, Ste B, Panama City Beach, FL 32407 Phone: 850-654-3937    Fax: 850-654-1070

Dr. William Charles Pike, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 10270 Front Beach Rd, Panama City Beach, FL 32407 Phone: 850-234-5340

The Eye Gallery Optometrist Medicare: Not Enrolled in Medicare Practice Location: 700 Pier Park Dr, Panama City Beach, FL 32413 Phone: 850-230-8350    Fax: 850-230-8340

Dr. Morris Howard Weaver, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10270 Front Beach Rd, Panama City Beach, FL 32407 Phone: 850-234-0775    Fax: 850-234-5701

Mona B Patel, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11570 Panama City Beach Pkwy, Suite 100, Panama City Beach, FL 32407 Phone: 850-230-4433

Panama City Beach Office Optometrist Medicare: Medicare Enrolled Practice Location: 10900 Hutchison Blvd, Panama City Beach, FL 32407 Phone: 850-234-1829    Fax: 850-233-5493

Tracy J. Beyer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11570 Panama City Beach Pkwy, Panama City Beach, FL 32407 Phone: 850-230-4433

News Archive

Lysteda tablets to treat menorrhagia approved by the FDA

The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.

TB drug isoniazid could reduce AIDS-related illnesses among children

The inexpensive tuberculosis drug isoniazid could help reduce by half the number of deaths from AIDS-related illnesses among children, according to a study published earlier this month in BMJ, the Pretoria News reports.

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange announced today the successful results of the Phase 1/2 study of its drug candidate CF102 in the treatment of hepatocellular carcinoma.

Dow, Habitat for Humanity expand partnership to address global housing, sanitation issues

The Dow Chemical Company and Habitat for Humanity announced today plans to expand their partnership in 2015 to address global housing and sanitation issues, helping thousands of families across five continents create decent, affordable housing. With first-time builds in Ethiopia, Argentina, Colombia and Nepal, Dow is increasing its support to a total of 30 countries since becoming Habitat's first national partner in 1983.

Read more Medical News

› Verified 1 days ago